The weekly litigation news digest is live. Subscribe now

(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof - EP2962690

The patent EP2962690 was granted to Amgen Europe on Jan 16, 2019. The application was originally filed on Mar 20, 2003 under application number EP15177140A. The patent is currently recorded with a legal status of "Revoked".

EP2962690

AMGEN EUROPE
Application Number
EP15177140A
Filing Date
Mar 20, 2003
Status
Revoked
Jan 22, 2025
Publication Date
Jan 16, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (17)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHEROct 16, 2019HAMM & WITTKOPPADMISSIBLE
CIPLAOct 16, 2019DOMPATENT VON KREISLER SELTING WERNERADMISSIBLE
CIPLAOct 16, 2019DOMPATENT VON PATENT UND RECHTSANWALTENADMISSIBLE
DR REDDYS LABORATORIESOct 16, 2019HAMM & WITTKOPPADMISSIBLE
GALENICUM HEALTH SLUOct 16, 2019GALENICUM HEALTH SLUADMISSIBLE
KRKAOct 16, 2019HOEFER & PARTNERADMISSIBLE
KRKAOct 16, 2019HOEFER & PARTNER PATENTANWALTE MBBADMISSIBLE
STADA ARZNEIMITTELOct 16, 2019HAMM & WITTKOPPADMISSIBLE
ZENTIVA KSOct 16, 2019HOFFMANN EITLEADMISSIBLE
HEXALOct 15, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
QUIMICA SINTETICAOct 15, 2019SCHONADMISSIBLE
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIOct 15, 2019SONNENHAUSERADMISSIBLE
GENERICS UKOct 11, 2019ELKINGTON AND FIFEADMISSIBLE
POLPHARMAOct 11, 2019ISARPATENTADMISSIBLE
ACCORD HEALTHCAREOct 10, 2019HOFFMANN EITLEADMISSIBLE
HOFFMANN EITLEOct 10, 2019HOFFMANN EITLEADMISSIBLE
TEVA PHARMACEUTICALSOct 3, 2019D YOUNGADMISSIBLE

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS3536809
DESCRIPTIONUS3598123
DESCRIPTIONUS3845770
DESCRIPTIONUS3916899
DESCRIPTIONUS4008719
DESCRIPTIONUS5059595
DESCRIPTIONUS5073543
DESCRIPTIONUS5120548
DESCRIPTIONUS5354556
DESCRIPTIONUS5591767
DESCRIPTIONUS5639476
DESCRIPTIONUS5674533
DESCRIPTIONUS5733566
DESCRIPTIONUS6020358
EXAMINATIONEP1752148
OPPOSITIONEP0238044
OPPOSITIONEP1485087
OPPOSITIONEP1752148
OPPOSITIONEP2074995
OPPOSITIONEP2962690
OPPOSITIONEP6023050
OPPOSITIONUS366515
OPPOSITIONUS6020358
OPPOSITIONUS6025376
OPPOSITIONWO0025777
OPPOSITIONWO03080049
SEARCHUS6020358

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents